Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria

• ABE Masanori

  Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine

• MARUYAMA Noriaki

  Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine

• OKADA Kazuyoshi

  Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine

• MATSUMOTO Shiro

  Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine

• MATSUMOTO Koichi

  Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine

• SOMA Masayoshi

  Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine

Journal

• Hypertens. Res.

  Hypertens. Res. 34 (8), 935-941, 2011-08-01

Keywords

• aldosterone
• calcium channel blocker
• chronic kidney disease
• diabetic nephropathy
• oxidant stress

Details

• CRID: 1570291225817207552
• NII Article ID: 10030275533
• NII Book ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2012323472
• Text Lang: en
• Data Source:
  • CiNii Articles